Gulino Richard L.

CIK 00016522082 companiesWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0001652208

Recent Transactions

34 trades

Tax Payment
InterDigital, Inc.$IDCC
Common Stock
2021-10-15$68.44/sh−1,922→ 20,520.704 total
Disposition to Issuer
InterDigital, Inc.$IDCC
Common Stock
2021-10-15$68.44/sh−0.712→ 20,519.993 total
Award
InterDigital, Inc.$IDCC
Common Stock
2021-10-15+6,216→ 22,442.704 total
Award
InterDigital, Inc.$IDCC
Common Stock
2021-07-28+74.773→ 16,226.704 total
Award
InterDigital, Inc.$IDCC
Common Stock
2021-04-28+68.522→ 16,151.931 total
Award
InterDigital, Inc.$IDCC
Common Stock
2021-03-31+6,620→ 16,083.409 total
Award
InterDigital, Inc.$IDCC
Common Stock
2021-01-27+38.278→ 9,463.409 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-10-28+45.371→ 9,425.132 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-07-22+42.752→ 9,379.761 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-06-15+3,030→ 10,266.009 total
Disposition to Issuer
InterDigital, Inc.$IDCC
Common Stock
2020-06-15$55.38/sh−929→ 9,337.009 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-04-22+16.269→ 7,236.009 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-03-31+5,042→ 7,219.74 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-01-22+5.74→ 2,177.74 total
Award
InterDigital, Inc.$IDCC
Common Stock
2020-01-15+1,210→ 2,172 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-03-01$18.71/sh−3,660→ 115,073 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2018-02-28+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-02-28+30,000→ 118,733 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-01-02+12,500→ 76,600 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2018-01-02−12,500→ 25,000 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-01-02$15.20/sh−10,367→ 88,733 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-01-02+7,500→ 99,100 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2018-01-02−7,500→ 15,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2017-03-01+30,000→ 39,100 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2017-03-01+70,000→ 70,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2017-01-03+7,500→ 20,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2017-01-03+12,500→ 12,500 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2017-01-03+12,500→ 37,500 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2017-01-03+7,500→ 22,500 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2017-01-03$15.51/sh−10,900→ 9,100 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2016-02-12+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2016-02-12+30,000→ 30,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2015-09-14+150,000→ 150,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2015-09-14+50,000→ 50,000 total

Companies

Recent Filings

Address

2200 PENNSYLVANIA AVENUE SUITE 300E

WASHINGTON, DC, 20037

View on SEC.gov